Skip to main content
TipRanks
Go Ultimate75% OFF

‘Stay Cool,’ Says Analyst About Rocket Lab Stock

‘Stay Cool,’ Says Analyst About Rocket Lab Stock
Image source: Shutterstock

Rocket Lab (NASDAQ:RKLB) investors were already a pretty depressed bunch before today, given the stock’s massive pullback from its May high, but Thursday’s action has made Wednesday’s closing price rather appealing.

The stock is being subjected to a heavy beating in today’s session, down by 13% as of writing, after the company announced the one thing investors did not want to hear: a debut launch delay for its Neutron rocket.

In a post-market update on Wednesday, Rocket Lab said Neutron’s maiden launch has been pushed back to 2027, having previously been targeted for the fourth quarter of 2026. The cause was a set of manufacturing flaws found in the propellant domes of the rocket’s first stage. The company says the problem has been fixed, but identifying the root cause and overhauling its production methods took long enough to knock the schedule back.

In January, a stage one tank burst during testing. Rocket Lab responded by bringing production of that tank in-house, aiming to gain efficiencies from its new automated fiber placement (AFP) machine. The original tank had been built by an outside supplier using hand-laid composite. At the same time, the company redesigned the structure to remove joints and add extra carbon composite thickness in certain sections. Those thicker sections later turned out to contain voids, which triggered an investigation and a revamp of the manufacturing process. Rocket Lab has since built a new aft dome and verified that the fix works, which gave it the green light to begin work on a replacement forward dome, now in progress. The result is that Neutron’s debut is now slated for no earlier than 2027.

As for what comes next, the company plans to fabricate, cure, analyze and test the new forward dome before the first quarter, with both domes expected to be joined into a complete first stage during Q1. After that, the rocket must clear a hydrostatic test, then a cryogenic test, and finally a full-stack test on the launch pad before it can fly.

So, following the disappointment, what should investors do with the stock now? Well, calm down a bit, appears to be KeyBanc analyst Michael Leshock’s stance. The analyst is not entirely surprised by this development. “We believe the delay was largely anticipated given management’s recent commentary, acknowledging that the window for a year-end launch was narrowing, and emphasizing the importance of balancing Neutron’s timeline with the ability to scale future production and launch cadence.”

Leshock now sees the second quarter of 2027 as a “reasonable timeline” for the first flight, while noting that a first-quarter launch is “not off the table upon execution.”

The analyst has left his 2026 forecasts untouched, as Neutron’s inaugural flight was never expected to bring in revenue. For 2027, however, he has trimmed his revenue estimate by roughly $53 million to account for one fewer paying Neutron mission that year. His projections for the Space Systems segment stay the same, as Leshock continues to expect robust growth there and regards Rocket Lab as a “top beneficiary of the fast-growing space ecosystem.”

“We believe the market sell-off presents a meaningful opportunity for growth-orientated, LT investors, as the LT story remains intact. We continue to view RKLB as a leader within the space sector and believe Neutron will achieve a commanding share of the medium-lift launch market over the coming years,” Leshock summed up.

That said, while Leshock maintained a Buy rating on the shares, he lowered his price target from $135 to $100 to “reflect the updated Neutron timeline and broader multiple compression across high-growth space equities.” Still, there’s potential upside of 96% from current levels. (To watch Leshock’s track record, click here)

Elsewhere on the Street, the stock claims an additional 14 Buys and 3 Holds for a Strong Buy consensus rating. The average price target clocks in at $100.75, implying the stock will gain 95% in the months ahead. (See RKLB stock forecast)

Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Disclaimer & DisclosureReport an Issue

Add as preferred source
Related Articles